PCAS (PCA) - Financial and Strategic SWOT Analysis Review
PCAS (PCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
PCAS, a subsidiary of Novocap SA, develops and manufactures complex molecules for life sciences and specialty chemicals markets. It designs and delivers the best industrial solutions for its customers' specific expectations. The company develops molecules used in pharmaceuticals, photographic products, glass, perfume, electronics, and petroleum. It also manufactures fine mineral chemicals and industrial specialty chemicals, and offers laboratory analysis services to petroleum products manufacturers. PCAS also develops ranges of proprietary products based on intellectual property. The company has operations in Europe, France, Asia Pacific, North America and Others. PCAS is headquartered in Longjumeau, France.
PCAS Key Recent Developments
Sep 07,2016: PCAS:1st Half 2016 Earnings Report Continued Organic Growth
Jul 19,2016: PCAS - Sustained Growth In Net Sales For The First Half Of 2016
Jul 12,2016: PCAS Signs a Global Distribution Agreement With Milliporesigma, Enabling A Better Access To Its Polymers Line Expansorb For Sustained Release Injectables
Apr 27,2016: PCAS: Corporate name change
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
PCAS, a subsidiary of Novocap SA, develops and manufactures complex molecules for life sciences and specialty chemicals markets. It designs and delivers the best industrial solutions for its customers' specific expectations. The company develops molecules used in pharmaceuticals, photographic products, glass, perfume, electronics, and petroleum. It also manufactures fine mineral chemicals and industrial specialty chemicals, and offers laboratory analysis services to petroleum products manufacturers. PCAS also develops ranges of proprietary products based on intellectual property. The company has operations in Europe, France, Asia Pacific, North America and Others. PCAS is headquartered in Longjumeau, France.
PCAS Key Recent Developments
Sep 07,2016: PCAS:1st Half 2016 Earnings Report Continued Organic Growth
Jul 19,2016: PCAS - Sustained Growth In Net Sales For The First Half Of 2016
Jul 12,2016: PCAS Signs a Global Distribution Agreement With Milliporesigma, Enabling A Better Access To Its Polymers Line Expansorb For Sustained Release Injectables
Apr 27,2016: PCAS: Corporate name change
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
PCAS - Key Facts
PCAS - Key Employees
PCAS - Major Products and Services
PCAS - History
PCAS - Company Statement
PCAS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
PCAS - Business Description
PCAS - SWOT Analysis
SWOT Analysis - Overview
PCAS - Strengths
PCAS - Weaknesses
PCAS - Opportunities
PCAS - Threats
PCAS - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
PCAS, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Sep 07, 2016: PCAS:1st Half 2016 Earnings Report Continued Organic Growth
Jul 19, 2016: PCAS - Sustained Growth In Net Sales For The First Half Of 2016
Jul 12, 2016: PCAS Signs a Global Distribution Agreement With Milliporesigma, Enabling A Better Access To Its Polymers Line Expansorb For Sustained Release Injectables
Apr 27, 2016: PCAS : Corporate name change
SECTION 5 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
PCAS - Key Facts
PCAS - Key Employees
PCAS - Major Products and Services
PCAS - History
PCAS - Company Statement
PCAS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
PCAS - Business Description
PCAS - SWOT Analysis
SWOT Analysis - Overview
PCAS - Strengths
PCAS - Weaknesses
PCAS - Opportunities
PCAS - Threats
PCAS - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
PCAS, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Sep 07, 2016: PCAS:1st Half 2016 Earnings Report Continued Organic Growth
Jul 19, 2016: PCAS - Sustained Growth In Net Sales For The First Half Of 2016
Jul 12, 2016: PCAS Signs a Global Distribution Agreement With Milliporesigma, Enabling A Better Access To Its Polymers Line Expansorb For Sustained Release Injectables
Apr 27, 2016: PCAS : Corporate name change
SECTION 5 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
PCAS, Key Facts
PCAS, Key Employees
PCAS, Major Products and Services
PCAS, History
PCAS, Other Locations
PCAS, Subsidiaries
PCAS, Joint Venture
PCAS, Key Competitors
PCAS, Ratios based on current share price
PCAS, Annual Ratios
PCAS, Annual Ratios (Cont...1)
PCAS, Annual Ratios (Cont...2)
PCAS, Interim Ratios
PCAS, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
PCAS, Key Facts
PCAS, Key Employees
PCAS, Major Products and Services
PCAS, History
PCAS, Other Locations
PCAS, Subsidiaries
PCAS, Joint Venture
PCAS, Key Competitors
PCAS, Ratios based on current share price
PCAS, Annual Ratios
PCAS, Annual Ratios (Cont...1)
PCAS, Annual Ratios (Cont...2)
PCAS, Interim Ratios
PCAS, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
PCAS, Performance Chart (2011 - 2015)
PCAS, Ratio Charts
COMPANIES MENTIONED
Multi-Chem Limited
Holliday Pigments SAS
Flex Ltd
EPC Groupe
CPH Ltd.
Compagnie Plastic Omnium
Arkema SA
PCAS, Performance Chart (2011 - 2015)
PCAS, Ratio Charts
COMPANIES MENTIONED
Multi-Chem Limited
Holliday Pigments SAS
Flex Ltd
EPC Groupe
CPH Ltd.
Compagnie Plastic Omnium
Arkema SA